284 related articles for article (PubMed ID: 19901558)
1. Anti-malaria drug blocks proteotoxic stress response: anti-cancer implications.
Neznanov N; Gorbachev AV; Neznanova L; Komarov AP; Gurova KV; Gasparian AV; Banerjee AK; Almasan A; Fairchild RL; Gudkov AV
Cell Cycle; 2009 Dec; 8(23):3960-70. PubMed ID: 19901558
[TBL] [Abstract][Full Text] [Related]
2. Proteotoxic stress targeted therapy (PSTT): induction of protein misfolding enhances the antitumor effect of the proteasome inhibitor bortezomib.
Neznanov N; Komarov AP; Neznanova L; Stanhope-Baker P; Gudkov AV
Oncotarget; 2011 Mar; 2(3):209-21. PubMed ID: 21444945
[TBL] [Abstract][Full Text] [Related]
3. Effect of inhibition of the ubiquitin-proteasome system and Hsp90 on growth and survival of rhabdomyosarcoma cells in vitro.
Peron M; Bonvini P; Rosolen A
BMC Cancer; 2012 Jun; 12():233. PubMed ID: 22691173
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin abrogates the geldanamycin-induced heat shock response.
McCollum AK; Lukasiewicz KB; Teneyck CJ; Lingle WL; Toft DO; Erlichman C
Mol Cancer Ther; 2008 Oct; 7(10):3256-64. PubMed ID: 18852129
[TBL] [Abstract][Full Text] [Related]
5. RhoA Activation Sensitizes Cells to Proteotoxic Stimuli by Abrogating the HSF1-Dependent Heat Shock Response.
Meijering RA; Wiersma M; van Marion DM; Zhang D; Hoogstra-Berends F; Dijkhuis AJ; Schmidt M; Wieland T; Kampinga HH; Henning RH; Brundel BJ
PLoS One; 2015; 10(7):e0133553. PubMed ID: 26193369
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity.
Mimnaugh EG; Xu W; Vos M; Yuan X; Isaacs JS; Bisht KS; Gius D; Neckers L
Mol Cancer Ther; 2004 May; 3(5):551-66. PubMed ID: 15141013
[TBL] [Abstract][Full Text] [Related]
7. Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications.
Spisek R; Charalambous A; Mazumder A; Vesole DH; Jagannath S; Dhodapkar MV
Blood; 2007 Jun; 109(11):4839-45. PubMed ID: 17299090
[TBL] [Abstract][Full Text] [Related]
8. The proteasome inhibitor bortezomib is a potent inducer of zinc finger AN1-type domain 2a gene expression: role of heat shock factor 1 (HSF1)-heat shock factor 2 (HSF2) heterocomplexes.
Rossi A; Riccio A; Coccia M; Trotta E; La Frazia S; Santoro MG
J Biol Chem; 2014 May; 289(18):12705-15. PubMed ID: 24619424
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of heat shock protein response enhances PS-341-mediated glioma cell death.
Liu Y; Zheng T; Zhao S; Liu H; Han D; Zhen Y; Xu D; Wang Y; Yang H; Zhang G; Wang C; Wu J; Ye Y
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S421-9. PubMed ID: 21732139
[TBL] [Abstract][Full Text] [Related]
10. Molecular stress-inducing compounds increase osteoclast formation in a heat shock factor 1 protein-dependent manner.
Chai RC; Kouspou MM; Lang BJ; Nguyen CH; van der Kraan AG; Vieusseux JL; Lim RC; Gillespie MT; Benjamin IJ; Quinn JM; Price JT
J Biol Chem; 2014 May; 289(19):13602-14. PubMed ID: 24692538
[TBL] [Abstract][Full Text] [Related]
11. Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis.
Powers MV; Clarke PA; Workman P
Cancer Cell; 2008 Sep; 14(3):250-62. PubMed ID: 18772114
[TBL] [Abstract][Full Text] [Related]
12. The Hsp90 inhibitor IPI-504 overcomes bortezomib resistance in mantle cell lymphoma in vitro and in vivo by down-regulation of the prosurvival ER chaperone BiP/Grp78.
Roué G; Pérez-Galán P; Mozos A; López-Guerra M; Xargay-Torrent S; Rosich L; Saborit-Villarroya I; Normant E; Campo E; Colomer D
Blood; 2011 Jan; 117(4):1270-9. PubMed ID: 21106982
[TBL] [Abstract][Full Text] [Related]
13. Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of hsp90-binding agents.
Bagatell R; Paine-Murrieta GD; Taylor CW; Pulcini EJ; Akinaga S; Benjamin IJ; Whitesell L
Clin Cancer Res; 2000 Aug; 6(8):3312-8. PubMed ID: 10955818
[TBL] [Abstract][Full Text] [Related]
14. Heat shock protein 90-binding agents protect renal cells from oxidative stress and reduce kidney ischemia-reperfusion injury.
Harrison EM; Sharpe E; Bellamy CO; McNally SJ; Devey L; Garden OJ; Ross JA; Wigmore SJ
Am J Physiol Renal Physiol; 2008 Aug; 295(2):F397-405. PubMed ID: 18562631
[TBL] [Abstract][Full Text] [Related]
15. The small-molecule kinase inhibitor D11 counteracts 17-AAG-mediated up-regulation of HSP70 in brain cancer cells.
Schaefer S; Svenstrup TH; Guerra B
PLoS One; 2017; 12(5):e0177706. PubMed ID: 28542269
[TBL] [Abstract][Full Text] [Related]
16. Activation of heat shock factor 1 plays a role in pyrrolidine dithiocarbamate-mediated expression of the co-chaperone BAG3.
Song S; Kole S; Precht P; Pazin MJ; Bernier M
Int J Biochem Cell Biol; 2010 Nov; 42(11):1856-63. PubMed ID: 20692357
[TBL] [Abstract][Full Text] [Related]
17. Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1.
Zou J; Guo Y; Guettouche T; Smith DF; Voellmy R
Cell; 1998 Aug; 94(4):471-80. PubMed ID: 9727490
[TBL] [Abstract][Full Text] [Related]
18. Endoplasmic reticulum vacuolization and valosin-containing protein relocalization result from simultaneous hsp90 inhibition by geldanamycin and proteasome inhibition by velcade.
Mimnaugh EG; Xu W; Vos M; Yuan X; Neckers L
Mol Cancer Res; 2006 Sep; 4(9):667-81. PubMed ID: 16966435
[TBL] [Abstract][Full Text] [Related]
19. Heat shock transcription factor 1-activating compounds suppress polyglutamine-induced neurodegeneration through induction of multiple molecular chaperones.
Fujikake N; Nagai Y; Popiel HA; Okamoto Y; Yamaguchi M; Toda T
J Biol Chem; 2008 Sep; 283(38):26188-97. PubMed ID: 18632670
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Hsp90 function delays and impairs recovery from heat shock.
Duncan RF
FEBS J; 2005 Oct; 272(20):5244-56. PubMed ID: 16218955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]